BenzingaAugust 12, 2026 at 7:38 AM NY2 Months Ago
Morgan Stanley Maintains Overweight on Biohaven, Raises Price Target to $19
Morgan Stanley analyst Terence Flynn maintains Biohaven (NYSE:BHVN) with a Overweight and raises the price target from $18 to $19.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
